Art therapy as a comprehensive complementary treatment for Parkinson's disease.
Parkinson’s disease
art based assessment
art making
art therapy
neurodegenerative disorder
Journal
Frontiers in human neuroscience
ISSN: 1662-5161
Titre abrégé: Front Hum Neurosci
Pays: Switzerland
ID NLM: 101477954
Informations de publication
Date de publication:
2023
2023
Historique:
received:
28
11
2022
accepted:
11
04
2023
medline:
30
5
2023
pubmed:
30
5
2023
entrez:
30
5
2023
Statut:
epublish
Résumé
Parkinson's disease (PD) is the second most prevalent neurodegenerative disease. Complementary and alternative therapies are increasingly utilized to address its complex multisystem symptomatology. Art therapy involves motoric action and visuospatial processing while promoting broad biopsychosocial wellness. The process involves hedonic absorption, which provides an escape from otherwise persistent and cumulative PD symptoms, refreshing internal resources. It involves the expression in nonverbal form of multilayered psychological and somatic phenomena; once these are externalized in a symbolic arts medium, they can be explored, understood, integrated, and reorganized through verbal dialogue, effecting relief and positive change. 42 participants with mild to moderate PD were treated with 20 sessions of group art therapy. They were assessed before and after therapy with a novel arts-based instrument developed to match the treatment modality for maximum sensitivity. The House-Tree-Person PD Scale (HTP-PDS) assesses motoric and visuospatial processing-core PD symptoms-as well as cognition (thought and logic), affect/mood, motivation, self (including body-image, self-image, and self- efficacy), interpersonal functioning, creativity, and overall level of functioning. It was hypothesized that art therapy will ameliorate core PD symptoms and that this will correlate with improvements in all other variables. HTP-PDS scores across all symptoms and variables improved significantly, though causality among variables was indeterminate. Art therapy is a clinically efficacious complementary treatment for PD. Further research is warranted to disentangle causal pathways among the aforementioned variables, and additionally, to isolate and examine the multiple, discrete healing mechanisms believed to operate simultaneously in art therapy.
Identifiants
pubmed: 37250693
doi: 10.3389/fnhum.2023.1110531
pmc: PMC10215005
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1110531Informations de copyright
Copyright © 2023 Ettinger, Berberian, Acosta, Cucca, Feigin, Genovese, Pollen, Rieders, Kilachand, Gomez, Kaimal, Biagioni, Di Rocco, Ghilardi and Rizzo.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Altern Complement Med. 2015 Apr;21(4):196-9
pubmed: 25848886
Complement Ther Med. 2019 Feb;42:A1-A3
pubmed: 30670289
Neurol Sci. 2019 Oct;40(10):2175-2178
pubmed: 31144156
J Clin Psychol. 1948 Oct;4(4):317; passim
pubmed: 18099717
Front Neurol. 2018 Jun 19;9:455
pubmed: 29971039
Medicine (Baltimore). 2017 Jan;96(3):e5836
pubmed: 28099340
Neurosci Biobehav Rev. 2016 Feb;61:26-34
pubmed: 26645499
Biomed Pharmacother. 2020 Nov;131:110776
pubmed: 33152935
Parkinsonism Relat Disord. 2021 Mar;84:148-154
pubmed: 33526323
Front Psychol. 2021 Jul 15;12:678397
pubmed: 34366998
NPJ Parkinsons Dis. 2016;2:
pubmed: 27239558
J Evid Based Integr Med. 2018 Jan-Dec;23:2515690X18765943
pubmed: 29607671
Front Psychol. 2022 Sep 26;13:906191
pubmed: 36225688
Art Ther (Alex). 2016 Apr 2;33(2):74-80
pubmed: 27695158
J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):727-33
pubmed: 11385004
PLoS One. 2014 Nov 13;9(11):e112348
pubmed: 25393414
Front Psychol. 2015 Aug 11;6:1195
pubmed: 26322002
Nature. 2005 Mar 17;434(7031):301-7
pubmed: 15772645
Life Sci. 2019 Jun 1;226:77-90
pubmed: 30980848
Ann Neurol. 2014 Jun;75(6):935-42
pubmed: 24816898
Neuropathology. 2020 Feb;40(1):30-39
pubmed: 31498507
Eur J Public Health. 2018 Jun 1;28(3):404-409
pubmed: 29462307
ScientificWorldJournal. 2010 Nov 16;10:2301-13
pubmed: 21103799
Parkinsons Dis. 2017;2017:7436725
pubmed: 29359066
Mov Disord Clin Pract. 2017 Nov 01;4(6):806-818
pubmed: 30363367
Pract Neurol. 2017 Dec;17(6):456-463
pubmed: 28844041
Cureus. 2022 Aug 7;14(8):e27750
pubmed: 36106206
J Neurosci Rural Pract. 2021 Apr;12(2):323-328
pubmed: 33986584
Lancet. 2015 Aug 29;386(9996):896-912
pubmed: 25904081
P T. 2015 Aug;40(8):504-32
pubmed: 26236139
Parkinsonism Relat Disord. 2013 Sep;19(9):825-6
pubmed: 23660546
Sci Rep. 2016 Dec 19;6:39185
pubmed: 27991592
J Korean Med Sci. 2018 Mar 19;33(12):e88
pubmed: 29542299
Neurol Res Int. 2010;2010:283890
pubmed: 21152211
Expert Rev Neurother. 2015 May;15(5):549-62
pubmed: 25936847
Front Neurosci. 2021 Nov 24;15:761817
pubmed: 34899165
J Parkinsons Dis. 2016 Jun 3;6(3):625-30
pubmed: 27285568
Intelligence. 2014 Sep;46:73-83
pubmed: 25278640
J Gerontol B Psychol Sci Soc Sci. 2020 Aug 13;75(7):1609-1619
pubmed: 31287550
BMJ. 2019 Mar 28;364:l1285
pubmed: 30923039
Mov Disord. 2010 Jan 30;25(2):194-204
pubmed: 20077478
Front Psychol. 2020 Sep 24;11:542444
pubmed: 33101117
Complement Ther Med. 2018 Oct;40:70-76
pubmed: 30219472